The military world is full of initialisms and acronyms. Many of these are well known, NATO, USAF, and RAF all spring to mind. But what about the US Navy's acronym — DEVGRU? The lesser-known status of ...

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

Fred Ramsdell was on vacation in the Montana wilderness when he and two colleagues received the honor for their breakthroughs ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...

Trials of vision-improving substances are showing good results, though so far only two have been authorized for use in the ...

When brain development gets off to a bad start, the consequences are lifelong. One example is a condition called SCN2A haploinsufficiency, in which children are born with just one functioning copy of ...

Genetic editing holds promise to treat incurable diseases, but the most popular method — CRISPR — sometimes does more harm than good. A new study from University of California San Diego and Yale ...

Shakespeare's Juliet asked, "What's in a name?" When it comes to M&M's, the answer is "A lot, actually." When sweet-toothed foodies pop those multicolored pebbles between their lips, the story behind ...

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers. Download the app ...

Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark ...

Hello, everyone. My name is Mitchell Kapoor. I'm a senior biotech analyst at H.C. Wainwright. Today, I have the pleasure of welcoming CRISPR Therapeutics. And from the company, Raj Prasad, CFO, is ...